The Hospital will use the SOPHiA DDM™ Platform to advance its research and diagnosis of blood...
Press releases
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2023
Robust growth and efficient expense execution continues BOSTON, United States and ROLLE,...
Tulane University School of Medicine Uses SOPHiA GENETICS to Advance Research of Blood Cancers
The School of Medicine will use the SOPHiA DDM™ Platform to expand its hematologic testing program...
SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2023 on August 8, 2023
BOSTON and ROLLE, Switzerland, July 25, 2023 — SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native...
SOPHiA GENETICS Supports SOFIVA GENOMICS to Launch New HRD Test
New HRD test uses SOPHiA DDM™ Platform to increase accuracy in HRD detection BOSTON and Rolle,...
SOPHiA GENETICS Announces Gruppo Centro Servizi Medici (CSM) is Live on the SOPHiA DDM™ Platform
CSM is using the SOPHiA DDM™ Platform to expand its next-generation sequencing (NGS) offerings
Centre Hospitalier de Bastia is Live on SOPHiA GENETICS
SOPHiA DDMTM Platform will bring next-generation sequencing in-house and help further research on...
SOPHiA GENETICS Publishes Results of 2023 Annual General Meeting
BOSTON and Rolle, Switzerland, June 26, 2023 – SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native...
Ankara Etlik City Hospital is Live on SOPHiA GENETICS Platform
SOPHiA GENETICS technology to aid research associated with hereditary cancers and disorders
NOMAD Genetics is Live on the SOPHiA GENETICS Platform
SOPHiA GENETICS technology aids NOMAD Genetics in the advancement of its cancer research...
SOPHiA GENETICS to Host Symposium at European Society of Human Genetics Annual Meeting
Leader in data-driven medicine will discuss progress in the adoption of exome and...
SOPHiA GENETICS Joins CancerX to Help Accelerate Cancer Research
As a leader in data-driven medicine, SOPHiA GENETICS lends its expertise to support White House Cancer Moonshot